A content analysis of direct-to-consumer television prescription drug advertisements

Journal of Health Communication

Volumn 9, Issue 6, 2004, Pages 515-528

  Kaphingst, Kimberly A ^a,b   Dejong, William ^c   Rudd, Rima E ^a   Daltroy, Lawren H ^a,d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BOSTON UNIVERSITY   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT; ANTIASTHMATIC AGENT; ANTIRHEUMATIC AGENT; HYPOCHOLESTEROLEMIC AGENT;

ARTICLE; CONSUMER; DRUG MARKETING; HUMAN; PRESCRIPTION; SIDE EFFECT; TELEVISION;

ADVERTISING; ATTITUDE TO HEALTH; CONSUMER SATISFACTION; DRUG INDUSTRY; HUMANS; INFORMATION DISSEMINATION; PERSUASIVE COMMUNICATION; PRESCRIPTIONS, DRUG; RISK; TELEVISION; UNITED STATES;

EID: 12244284650     PISSN: 10810730     EISSN: None     Source Type: Journal    
DOI: 10.1080/10810730490882586     Document Type: Article

References (52)

1. Aikin, K. J. (2002). Direct-to-consumer advertising of prescription drugs: Patient survey results. U.S. Food and Drug Administration, Division of Drug Marketing, Advertising and Communications. Retrieved August 2, 2003, from http://www.fda.gov/cder/ddmac/presentations.htm.
2. Aikin, K. J. (2003). Direct-to-consumer advertising of prescription drugs: Physician survey preliminary results. U.S. Food and Drug Administration, Division of Drug Marketing, Advertising and Communications. Retrieved August 2, 2003, from http://www.fda.gov/cder/ddmac/ presentations.htm.
3. Avorn, J. (2003). Advertising and prescription drugs: Promotion, education, and the public's health. Health Affairs, W3-104-W3-108 [On-line]. Available: http://www.healthaffairs.org/WebExclusives/Pharma_Web_Excl_022603. htm.
4. Baker, D. W., Williams, M. V., Parker, R. M., & Nurss, J. R. (1996). Inadequate functional health literacy (letter to the editor). JAMA, 275(11), 840.
5. Baylor-Henry, M. & Drezin, N. A. (1998). Regulation of prescription drug promotion: Direct-to-consumer advertising. Clinical Therapeutics, 20(Suppl. C), C86-C95.
6. Bell, R. A., Kravitz, R. L., & Wilkes, M. S. (2000a). Direct-to-consumer prescription drug advertising, 1989-1998. Journal of Family Practice, 49(4), 329-335.
7. Bell, R. A., Wilkes, M. S., & Kravitz, R. L. (2000b). The educational value of consumer-targeted prescription drug print advertising. Journal of Family Practice, 49, 1092-1098.
8. Bodenheimer, T. (2003). Two advertisements for TV drug ads. Health Affairs, W3-112-W3-115 [On-line]. Available: http://www.healthaffairs.org/ WebExclusives/Pharma_Web_Excl_ 022603.htm
9. Bradley, L. R. & Zito, J. M. (1997). Direct-to-consumer prescription drug advertising. Medical Care, 35(1), 86-92.
10. Brinberg, D. & Morris, L. A. (1987). Advertising prescription drugs to consumers. Advances in Marketing and Public Policy, 1, 1-40.
11. Cohen, E. P. (1988). Direct-to-the-public advertisement of prescription drugs. New England Journal of Medicine, 318, 373.
12. Committee on Drugs. (1991). Prescription drug advertising direct to the consumer. Pediatrics, 88(1), 174-175.
13. Consumer Reports. (1996). Drug advertising: Is this good medicine? Consumer Reports, 61(6), 62-63.
14. Consumer Reports. (2003). Free rein for drug ads? Consumer Reports, 68(2), 33-37.
15. Cunningham, A. E. & Stanovich, K. E. (1998). What reading does for the mind. American Educator, 22, 8-15.
16. Everitt, B. S. & Hay, D. F. (1992). Talking about statistics: A psychologist's guide to data analysis. New York: Halsted Press.
17. Flay, B. R., DiTecco, D., & Schlegel, R. P. (1980). Mass media in health promotion: An analysis using an extended information-processing model. Health Education Quarterly, 7(2), 127-147.
18. Frank, R. G., Berndt, E. R., Donohue, J. M., Epstein, A. M., & Rosenthal, M. B. (2002). Trends in direct-to-consumer advertising of prescription drugs. Menlo Park, CA: Kaiser Family Foundation.
19. Gahart, M. T., Duhamel, L. M., Dievler, A., & Price, R. (2003). Examining the PDA's oversight of direct-to-consumer advertising. Health Affairs, W3-120-W3-123 [On-line]. Available: http://www.healthaffairs.org/WebExclusives/ Pharma_Web_Excl_022603.htm.
20. Hoffman, J. R. & Wilkes, M. (1999). Direct to consumer advertising of prescription drugs: An idea whose time should not come. British Medical Journal, 318(7194), 1301-1302.
21. Holmer, A. F. (1999). Direct-to-consumer prescription drug advertising builds bridges between patients and physicians. JAMA, 281(4), 380-382.
22. Kaiser Family Foundation. (2001). Understanding the effects of direct-to-consumer prescription drug advertising. Menlo Park, CA: Author.
23. Kessler, D. A. & Pines, W. L. (1990). The federal regulation of prescription drug advertising and promotion. JAMA, 264(18), 2409-2415.
24. Kirsch, I. S., Jungeblut, A., Jenkins, L., & Kolstad, A. (1993). Adult literacy in America: A first look at the results of the National Adult Literacy Survey. Washington, DC: National Center for Education Statistics, U.S. Department of Education.
25. Lexchin, J. (1997). What information do physicians receive from pharmaceutical representatives. Canadian Family Physician, 43, 941-945.
26. Masson, A. & Rubin, P. H. (1985). Matching prescription drugs and consumers. New England Journal of Medicine, 313, 513-515.
27. Mayeaux, E. J., Murphy, P. W., Arnold, C., Davis, T. C., Jackson, R. H., & Sentell, T. (1996). Improving patient education for patients with low literacy skills. American Family Physician, 53(1), 205-211.
28. McGuire, W. J. (1984). Public communication as a strategy for inducing health-promoting behavioral change. Preventive Medicine, 13, 299-319.
29. McGuire, W. J. (1985). Attitudes and attitude change. In G. Lindzey & E. Aronson (Eds.), Handbook of social psychology (3rd ed., vol. II, pp. 233-346). New York: Random House.
30. McGuire, W. J. (1989). Theoretical foundations of campaigns. In R. E. Rice & C. K. Atkin (Eds.), Public communication campaigns (2nd ed., pp. 43-65). Newbury Park, CA: Sage Publications.
31. Miller, C. (1994). Drug firms boost pitch directly to consumers. Marketing News, 28, 1.
32. Morris, L. A., Brinberg, D., Klimberg, R., Millstein, L., & Rivera, C. (1986). Consumer attitudes about advertisements for medicinal drugs. Social Science and Medicine, 22(6), 629-638.
33. Nordenberg, T. (1998). Direct to you: TV drug ads that make sense. FDA Consumer, 32(1), 7-10.
34. Office of Cancer Communications, National Cancer Institute. (1989). Making health communication programs work: A planner's guide. Bethesda, MD: Author.
35. Ostrove, N. M. (2001). Statement of Nancy M. Ostrove, Ph.D., Deputy Director, Division of Drug Marketing, Advertising and Communications, Center for Drug Evaluation and Research, Food and Drug Administration, Department of Health and Human Services, before the Subcommittee on Consumer Affairs, Foreign Commerce, and Tourism, Senate Committee on Commerce, Science, and Transportation. Retrieved November 4, 2002, from http://www.fda.gov/ola/2001/ drugpromo0724.html
36. Pinto, M. B. (2000). On the nature and properties of appeals used in direct-to-consumer advertising of prescription drugs. Psychological Reports, 86, 597-607.
37. Reeves, K. N. (1998). Direct-to-consumer broadcast advertising: Empowering the consumer or manipulating a vulnerable population? Food and Drug Law Journal, 53, 661-679.
38. Rosenthal, M. B., Berndt, E. R., Donohue, J. M., Frank, R. G., & Epstein, A. M. (2002). Promotion of prescription drugs to consumers. New England Journal of Medicine, 346(7), 498-505.
39. Roth, M. S. (1996). Patterns in direct-to-consumer prescription drug print advertising and their public policy implications. Journal of Public Policy and Marketing, 15(1), 63-75.
40. Schommer, J. C., Doucette, W. R., & Mehta, B. H. (1998). Rote learning after exposure to a direct-to-consumer television advertisement for a prescription drug. Clinical Therapeutics, 20(3), 617-632.
41. SPSS Inc. (1999). SPSS base 10.0 applications guide. Chicago, IL: Author.
42. 't Hoen, E. (1998). Direct-to-consumer advertising: For better profits or for better health. American Journal of Health-System Pharmacy, 55, 594-597.
43. Talley, C. R. (1997). Direct-to-consumer prescription drug advertising. American Journal of Health-System Pharmacy, 54, 2181.
44. Terzian, T. V. (1999). Direct-to-consumer prescription drug advertising. American Journal of Law and Medicine, 25(1), 149-167.
45. U.S. Food and Drug Administration (FDA). (1997). FDA to review standards for all direct-to-consumer Rx drug promotion. U.S. Food and Drug Administration, U.S. Department of Health and Human Services. Retrieved August 2, 2003, from http://www.fda.gov/bbs/topics/NEWS/NEW00582.html.
46. U.S. Food and Drug Administration (FDA). (1999). Guidance for industry, consumer-directed broadcast advertisements. U.S. Food and Drug Administration, U.S. Department of Health and Human Services. Retrieved August 2, 2003, from http://www.fda.gov/cder.
47. U.S. General Accounting Office. (2002). Prescription drugs: FDA oversight of direct-to-consumer advertising has limitations (GAO-03-177). Washington, DC: Author.
48. Weissman, J. S., Blumenthal, D., Silk, A. J., Zapert, K., Newman, M., & Leitman, R. (2003). Consumers' reports on the health effects of direct-to-consumer drug advertising. Health Affairs, W3-82-W3-95 [On-line]. Available: http://www.healthaffairs.org/WebExclusives/Pharma_Web_Excl_022603. htm.
49. Whyte, J. (1993). Direct consumer advertising of prescription drugs. JAMA, 268(25), 146, 150.
50. Wilkes, M. S., Bell, R. A., & Kravitz, R. L. (2000). Direct-to-consumer prescription drug advertising: Trends, impact, and implications. Health Affairs, 19(2), 110-128.
51. Woloshin, S., Schwartz, L. M., Tremmel, J., & Welch, H. G. (2001). Direct-to-consumer advertisements for prescription drugs: What are Americans being sold? Lancet, 358, 1141-1146.
52. Woodcock, J. (2003). Statement by Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Department of Health and Human Services, before the Senate Special Committee on Aging. Retrieved August 8, 2003, from http://www.fda.gov/olda/2003/ AdvertisingofPrescriptionDrugs0722.html.